FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016030626> ?p ?o ?g. }

• W2016030626 endingPage "30" @default.
• W2016030626 startingPage "25" @default.
• W2016030626 abstract "The preliminary results of intraarterial chemotherapy with peptichemio, doxorubicin, and cisplatin as part of a multimodality treatment in locally advanced and recurrent cervical carcinomas are reported. Treatment consisted of a bilateral sequential infusion of peptichemio 20 mg, doxorubicin 10 mg and cisplatin 20 mg in a 6-hour period via an external infusion pump. After a rest period of 4 days, treatment restarted until maximum response or toxicity. Twenty-five patients, 12 with primary advanced (four Stage IIb, eight Stage III) and 13 with recurrent tumors were treated. All previously untreated patients obtained objective response. In particular, two patients with Stage IIb and III disease, respectively, achieved a complete response. Nine of 13 patients with recurrent disease (69%) were responsive, too, and therefore an overall objective response rate of 84% was achieved. Responses were noted after a median of five cycles of chemotherapy, whereas hematologic toxicity observed in all but one patient, was encountered after a median of four cycles. Toxicity of grade 1 and 2 was noted in 19 patients (76%), whereas of grade 3 and 4 in only 5 (20%). One treatment-related death, due to sepsis during myelosuppression, was reported. Catheter-related toxicity was noted in four patients causing femoral thrombosis in two. In one case a bypass operation was required. After intraarterial chemotherapy, all 21 responsive patients were eligible for radical surgery and 18 (86%) underwent both surgery and postoperative radiation therapy. Surgery was excluded in three patients. In these three cases radiation therapy alone was employed. In this series, the schedule of intraarterial chemotherapy employed was very effective. Patient accrual is ongoing in order to confirm the response rate so far obtained and to evaluate, with a longer follow-up, the impact of this multidisciplinary approach on local control and survival." @default.
• W2016030626 created "2016-06-24" @default.
• W2016030626 creator A5007883886 @default.
• W2016030626 creator A5010757372 @default.
• W2016030626 creator A5011586702 @default.
• W2016030626 creator A5015952023 @default.
• W2016030626 creator A5021100005 @default.
• W2016030626 creator A5032404109 @default.
• W2016030626 creator A5048971171 @default.
• W2016030626 creator A5062414650 @default.
• W2016030626 creator A5065156213 @default.
• W2016030626 creator A5066013189 @default.
• W2016030626 creator A5071354389 @default.
• W2016030626 creator A5073892178 @default.
• W2016030626 date "1987-07-01" @default.
• W2016030626 modified "2023-09-24" @default.
• W2016030626 title "Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervix" @default.
• W2016030626 cites W1878603103 @default.
• W2016030626 cites W1964327353 @default.
• W2016030626 cites W1976685924 @default.
• W2016030626 cites W1994895995 @default.
• W2016030626 cites W1997109941 @default.
• W2016030626 cites W2009793041 @default.
• W2016030626 cites W2016492998 @default.
• W2016030626 cites W2017224028 @default.
• W2016030626 cites W2022369253 @default.
• W2016030626 cites W2028502906 @default.
• W2016030626 cites W2041461190 @default.
• W2016030626 cites W2042949813 @default.
• W2016030626 cites W2055290059 @default.
• W2016030626 cites W2071015671 @default.
• W2016030626 cites W2111977357 @default.
• W2016030626 cites W2142886194 @default.
• W2016030626 cites W2147380522 @default.
• W2016030626 cites W2148029244 @default.
• W2016030626 cites W2167805334 @default.
• W2016030626 cites W2181816749 @default.
• W2016030626 cites W284425476 @default.
• W2016030626 cites W67746198 @default.
• W2016030626 doi "https://doi.org/10.1002/1097-0142(19870701)60:1<25::aid-cncr2820600106>3.0.co;2-5" @default.
• W2016030626 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3581031" @default.
• W2016030626 hasPublicationYear "1987" @default.
• W2016030626 type Work @default.
• W2016030626 sameAs 2016030626 @default.
• W2016030626 citedByCount "29" @default.
• W2016030626 countsByYear W20160306262012 @default.
• W2016030626 crossrefType "journal-article" @default.
• W2016030626 hasAuthorship W2016030626A5007883886 @default.
• W2016030626 hasAuthorship W2016030626A5010757372 @default.
• W2016030626 hasAuthorship W2016030626A5011586702 @default.
• W2016030626 hasAuthorship W2016030626A5015952023 @default.
• W2016030626 hasAuthorship W2016030626A5021100005 @default.
• W2016030626 hasAuthorship W2016030626A5032404109 @default.
• W2016030626 hasAuthorship W2016030626A5048971171 @default.
• W2016030626 hasAuthorship W2016030626A5062414650 @default.
• W2016030626 hasAuthorship W2016030626A5065156213 @default.
• W2016030626 hasAuthorship W2016030626A5066013189 @default.
• W2016030626 hasAuthorship W2016030626A5071354389 @default.
• W2016030626 hasAuthorship W2016030626A5073892178 @default.
• W2016030626 hasConcept C126322002 @default.
• W2016030626 hasConcept C126894567 @default.
• W2016030626 hasConcept C141071460 @default.
• W2016030626 hasConcept C146357865 @default.
• W2016030626 hasConcept C151730666 @default.
• W2016030626 hasConcept C2776694085 @default.
• W2016030626 hasConcept C2778239845 @default.
• W2016030626 hasConcept C2778384902 @default.
• W2016030626 hasConcept C2781303535 @default.
• W2016030626 hasConcept C29730261 @default.
• W2016030626 hasConcept C509974204 @default.
• W2016030626 hasConcept C71924100 @default.
• W2016030626 hasConcept C86803240 @default.
• W2016030626 hasConceptScore W2016030626C126322002 @default.
• W2016030626 hasConceptScore W2016030626C126894567 @default.
• W2016030626 hasConceptScore W2016030626C141071460 @default.
• W2016030626 hasConceptScore W2016030626C146357865 @default.
• W2016030626 hasConceptScore W2016030626C151730666 @default.
• W2016030626 hasConceptScore W2016030626C2776694085 @default.
• W2016030626 hasConceptScore W2016030626C2778239845 @default.
• W2016030626 hasConceptScore W2016030626C2778384902 @default.
• W2016030626 hasConceptScore W2016030626C2781303535 @default.
• W2016030626 hasConceptScore W2016030626C29730261 @default.
• W2016030626 hasConceptScore W2016030626C509974204 @default.
• W2016030626 hasConceptScore W2016030626C71924100 @default.
• W2016030626 hasConceptScore W2016030626C86803240 @default.
• W2016030626 hasIssue "1" @default.
• W2016030626 hasLocation W20160306261 @default.
• W2016030626 hasLocation W20160306262 @default.
• W2016030626 hasOpenAccess W2016030626 @default.
• W2016030626 hasPrimaryLocation W20160306261 @default.
• W2016030626 hasRelatedWork W1993377100 @default.
• W2016030626 hasRelatedWork W2073683604 @default.
• W2016030626 hasRelatedWork W2161046978 @default.
• W2016030626 hasRelatedWork W2355670240 @default.
• W2016030626 hasRelatedWork W2361721102 @default.
• W2016030626 hasRelatedWork W2362144381 @default.
• W2016030626 hasRelatedWork W2376593068 @default.
• W2016030626 hasRelatedWork W2381952599 @default.

• next